Skip to main content

Dominique Cerutti, CEO of Altran: "A New Paradigm for R&D"

Altran quotes Ad Scientiam in an article in Forbes magazine on June 11, 2018:

"In health, in France, we have just announced that we will accompany the start-up Ad Scientiam to develop a medical device for real-life daily monitoring of patients with multiple sclerosis." 

Read the article

Latest News

No news available.